Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Gladigen

2015 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Operator of a biotechnology company specializing in peripheral nerve repair. The company designs, develops and commercializes technology that aligns and seals nerves severed by disease, traumatic events or surgical procedures, overcoming complications from the misdirection and loss of axons.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 4586 South West 48th Way
  • Suite 106
  • Gainesville, FL 32608
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Gladigen’s full profile, request a free trial.

Gladigen Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Gladigen Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
UF Innovate Accelerator/Incubator 000 0000 000000 0

Gladigen Executive Team (1)

Name Title Board
Seat
Contact
Info
Christopher Gladin Ph.D Chief Executive Officer